Orion Biotech Opportunities Corp. Units
ORIAU
ORIAU was delisted on the 25th of April, 2023.
11 hedge funds and large institutions have $21M invested in Orion Biotech Opportunities Corp. Units in 2022 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 2 closing their positions.
0% more funds holding
Funds holding: 11 → 11 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
17% less capital invested
Capital invested by funds: $25.1M → $21M (-$4.18M)
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$101K |
| 2 |
Jane Street
New York
|
+$26K |
| 3 |
CS
Clear Street
New York
|
+$18.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Calamos Advisors
Naperville,
Illinois
|
-$3.7M |
| 2 |
SMA
Sage Mountain Advisors
Atlanta,
Georgia
|
-$594K |
| 3 |
WC
Wealthspring Capital
West Harrison,
New York
|
-$39.4K |
| 4 |
Millennium Management
New York
|
-$31.8K |
| 5 |
MF
Magnetar Financial
Evanston,
Illinois
|
-$4.86K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
JP
1
JNE Partners
London,
United Kingdom
| $14.8M | – | – | – |
|
|
2
Jane Street
New York
| $3.68M | +$26K | +2,640 | +0.7% |
|
|
WC
3
Wealthspring Capital
West Harrison,
New York
| $972K | -$39.4K | -4,000 | -4% |
|
|
SIA
4
Schechter Investment Advisors
Birmingham,
Michigan
| $924K | – | – | – |
|
|
5
Millennium Management
New York
| $323K | -$31.8K | -3,227 | -9% |
|
|
SMA
6
Sage Mountain Advisors
Atlanta,
Georgia
| $149K | -$594K | -60,330 | -80% |
|
|
7
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $101K | +$101K | +10,288 | New |
|
|
CS
8
Clear Street
New York
| $19K | +$18.7K | +1,900 | New |
|
|
6CM
9
683 Capital Management
New York
| $10K | – | – | – |
|
|
WAM
10
Wolverine Asset Management
Chicago,
Illinois
| $9K | – | – | – |
|
11
UBS Group
Zurich,
Switzerland
| $1K | – | – | – |
|
|
MF
12
Magnetar Financial
Evanston,
Illinois
| – | -$4.86K | -492,000 | Closed |
|
|
13
Calamos Advisors
Naperville,
Illinois
| – | -$3.7M | -375,000 | Closed |
|
ORIAU Hedge Fund Activity: Q3 2022 in Review
11 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Orion Biotech Opportunities Corp. Units (ORIAU) for Q3 2022, worth a combined $21M — down 17% from $25.1M a quarter earlier.
Fund positioning in ORIAU was balanced in Q3 2022: 2 funds opened new positions, 2 closed out, 1 added to existing stakes and 3 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $101K. The largest seller was Calamos Advisors, exiting entirely with an estimated $3.7M sold.
- 11 institutional investors held Orion Biotech Opportunities Corp. Units (ORIAU) as of Q3 2022, unchanged from Q2 2022.
- Funds reported $21M of Orion Biotech Opportunities Corp. Units stock for Q3 2022, down 17% quarter-over-quarter.
- 2 funds opened new Orion Biotech Opportunities Corp. Units positions in Q3 2022 and 2 closed out, a net change of 0 holders.
- The largest Orion Biotech Opportunities Corp. Units buyer in Q3 2022 was Susquehanna International Group, an estimated $101K added.
- The largest Orion Biotech Opportunities Corp. Units seller in Q3 2022 was Calamos Advisors, an estimated $3.7M sold.
Based on aggregated 13F filings for Q3 2022.